GTR 71367821
Tenders Are Invited For Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
ICB — International Competitive Bid
Closes Dec 31, 2026
Western Europe
Tender Information
GTR Reference
71367821
Tendering Authority
Subscribe to view
Tender No
626106-2023
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-12-2026
Work Detail
Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.. The Commercial Health Insurance Company - Kkh (Hereinafter Kkh) Pursues The Goal Of Working With Everyone Suitable Pharmaceutical Companies Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V About The Active Ingredient (Atc) Mentioned Under Bt-21 Lot And, If Necessary, Limiting To Certain Ones Dosage Forms As Part Of A So-Called “Open House Procedure”. With The Provision Of Uniform Contractual Conditions And A Uniform Access Procedure Will Be Available To All Appropriate And Interested Pharmaceutical Companies Or Communities Pharmaceutical Companies Conclude Or Join A Discount Agreement § 130A Paragraph 8 Sgb V For The Above-Mentioned Active Ingredient. Those Interested In Pharmaceuticals Companies Can Submit The Participation Documents And Documents To The Contact Address Provided Request The Contract. The Prerequisite For Concluding A Contract Is That: Interested Pharmaceutical Companies Complete The Requested Participation Documents Completed And Signed. With Every Pharmaceutical Company That If The Participation Requirements Are Met, A Contract Is Concluded. An Exclusivity Is Not Given. You Can Join Or Conclude A Contract At Any Time And At Any Time Same Conditions. Individual Contract Negotiations Will Not Be Carried Out. Should The Kkh Issue A Tender For The Active Ingredients During The Contract Term? Of Exclusive Contracts In The Form Of The Open Procedure, The Framework Contracts Concluded In This Publication In Accordance With The Contractual Regulations Completed.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
9439959c-2363-4de5-ae46-b9ac7934ecd0.html
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.